Silence Therapeutics Plc has entered a second collaboration in under a month, this time with an unidentified pharmaceutical company to exploit Silence’s RNAi delivery technology. The follows an earlier agreement with a Dutch company in therapeutics. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
